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Dear Editor,
We read with interest the article by Zou et al. (1), pub-
lished in March 2016. In their retrospective study of 631 
patients, the authors concluded that the performance 
of the albumin-bilirubin (ALBI) score was comparable 
with that of Child-Pugh and model for end-stage liver 
disease (MELD) scores for predicting the in-hospital 
mortality of patients with acute upper gastrointestinal 
bleeding (GIB) and liver cirrhosis (2). However, the au-
thors did not compare GIB with other types of decom-
pensated cirrhosis.
In our unit, we conducted a retrospective cohort 
study including 106 patients (age 60.3±10.7 years; 
87.7% men) (admitted for acute decompensation of 
liver cirrhosis between January 2014 and December 
2015. We excluded patients with multicentric hepato-
cellular carcinoma or severe chronic extra-hepatic dis-
ease. Clinical manifestations included ascites (58.5%), 
hepatic encephalopathy (46.2%), portal hypertensive 
GIB (39.6%), acute kidney injury (38.7%), and infection 
(36.8%). In the group of patients with GIB (n=42), most 
presented with bleeding from esophageal or gastric 
varices (81%). MELD, Child-Pugh, and ALBI scores were 
calculated, and in-hospital mortality (MH) and mortal-
ity at 28 days (M28), 90 days (M90), and 1 year (M1y) 
were assessed. 
The area under receiver operating characteristic curves 
(AUROCs) of ALBI, Child-Pugh, and MELD scores for 
predicting mortality were as follows (n=106): for MH, 
0.676±0.073, 0.765±0.059, and 0.854±0.051, respective-
ly; for M28, 0.736±0.068, 0.798±0.051, and 0.805±0.064, 
respectively; for M90, 0.790±0.049, 0.818±0.040, and 
0.822±0.047 respectively; and for M1y, 0.728±0.049, 
0.763±0.045, and 0.718±0.049, respectively. 
Considering patients with GIB (n=42), AUROCs of ALBI, 
Child-Pugh, and MELD scores were as follows: for MH, 
0.815±0.090, 0.762±0.106, and 0.736±0.113, respective-
ly; for M28, 0.886±0.067, 0.884±0.062, and 0.801±0.102, 
respectively; for M90, 0.919±0.045, 0.886±0.050, and 
0.760±0.088, respectively; and for M1y, 0.868±0.059, 
0.845±0.066, and 0.684±0.090, respectively. Therefore, 
ALBI was always superior to MELD and Child-Pugh for 
patients with GIB, although this difference is only statis-
tically significant in the comparison with MELD for M90 
(0.046/ borderline) and M1y (p=0.007).
We highlight two findings from these results. In our 
group, MELD tended to perform better predicting MH 
and M28 than predicting M90 and M1y, whereas ALBI 
and Child-Pugh were better predictors of longer term 
mortality, namely M90. In addition, as in the study by 
Zou et al., ALBI was particularly accuratein patients with 
GIB (although these authors only included patients 
with upper GIB). 
One possibility is that, in acute decompensations 
involving multiorgan dysfunction, MELD is a better 
model (namely by including creatinine), whereas ALBI 
is superior as a model of liver dysfunction. Indeed, 
in our group, patients with GIB had lower creatinine 
levels compared with the other patients (1.22 vs. 1.59 
mg/dL; p=0.010) and had less acute-on-chronic liver 
failure (26.2% vs. 42.2%; p=0.103). Compared with 
Child-Pugh for patients with GIB, ALBI presented a 
similar performance and had the advantage of being 
more objective.
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To the Editor,
We thank Dr. Cardoso et al. (1) for their interest in our 
findings that the performance of albumin-bilirubin (ALBI) 
score has a higher accuracy than the Child-Pugh and 
model for end-stage liver disease (MELD) scores for pre-
dicting the in-hospital mortality in 631 cirrhotic patients 
with upper gastrointestinal bleeding (GIB) but that the 
difference was not statistically significant (2). Similarly, 
Cardoso et al. (1) found that the performance of the ALBI 
score was superior to that of the MELD and Child-Pugh 
scores for predicting the in-hospital, 28-day, 90-day, and 
1-year mortality in 42 cirrhotic patients with GIB and that 
the difference between 90-day and 1-year mortality was 
statistically significant.
In addition, further analyses by Cardoso et al. (1) suggested 
that the performance of MELD score was superior for pre-
dicting mortality in patients with acute decompensation 
involving multiorgan dysfunction. Our previous systematic 
review and meta-analysis suggested that the performance 
of MELD score had a higher specificity than the Child-Pugh 
score for the assessment of prognosis in patients with acute-
on-chronic liver failure (3). Our previous retrospective study 
also found that the performance of MELD score, rather than 
the ALBI or Child-Pugh score, could significantly predict the 
mortality of patients with acute-on-chronic liver failure di-
agnosed by the Asian Pacific Association for the Study of the 
Liver criteria (4).
We acknowledge that studies both by our team and by Car-
doso et al. were retrospective (1,2). 
In summary, the prognostic assessment of liver cirrhosis is of-
ten complicated (5). The indications of the ALBI, Child-Pugh, 
and MELD scores are heterogeneous. In the future, we should 
perform larger, well-designed prospective studies to identify a 
specific target population suitable for prognostic assessment 
by the ALBI, Child-Pugh, and MELD scores.
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